Skip to content
★ Sign in to follow
PC
Total declarations
153
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (62 ops.)
€20.0M

Latest filing published 09 Sept 2021 for KYNTRA BIO, INC., €22k.

Filing timeline

BuySale
Pat Cotroneo

Insider track record

Disclosed buys
0
Disclosed sells
62
Signal history

Pat Cotroneo: trading record in brief

Pat Cotroneo appears in our data through filings on Kyntra Bio, Inc. shares, published by SEC (Form 4). In total, 153 filings cover trades dated from 14 March 2015 to 7 September 2021.

Sales make up the whole of the open-market record (62 sales, €20.0M). Other entries cover 39 share grants and 52 option exercises. In 2021 alone, the filings show no purchases and 1 sale.

The newest entry dates from 9 September 2021: a share grant of €22k, in Kyntra Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Pat Cotroneo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations152 total
  • ◆
    Executive Advisor & Former CFOExecutivesKyntra Bio, Inc.
    26,570 USD21SEC
    2,141 shares@ US$12.4115.1% of flowCommon StockSEC:0001209191-21-055405:0
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    103,838 USD25SEC
    4,053 shares@ US$25.6257.8% of flowCommon StockSEC:0001209191-21-041808:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    49,029 USD22SEC
    2,141 shares@ US$22.9027.1% of flowCommon StockSEC:0001209191-21-039294:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    188,774 USD19SEC
    5,657 shares@ US$33.370.6% of flowCommon StockSEC:0001209191-21-019551:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    0SEC
    21,700 shares0Common StockSEC:0001209191-21-015009:0
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    133,765 USD31SEC
    3,068 shares@ US$43.603.5% of flowCommon StockSEC:0001209191-20-064227:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    126,558 USD19SEC
    3,014 shares@ US$41.993.3% of flowCommon StockSEC:0001209191-20-062617:0
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    133,944 USD31SEC
    3,070 shares@ US$43.633.2% of flowCommon StockSEC:0001209191-20-050998:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    127,070 USD19SEC
    3,014 shares@ US$42.163.0% of flowCommon StockSEC:0001209191-20-050048:0
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    18,893 USD19SEC
    637 shares@ US$29.660.5% of flowCommon StockSEC:0001209191-20-049618:0
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    110,445 USD19SEC
    5,696 shares@ US$19.392.6% of flowCommon StockSEC:0001209191-20-049618:1
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    220,243 USD20SEC
    8,671 shares@ US$25.405.2% of flowCommon StockSEC:0001209191-20-049618:2
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    763,854 USD33SEC
    15,004 shares@ US$50.9118.2% of flowCommon StockSEC:0001209191-20-049618:3
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    437,322 USD20SEC
    22,554 shares@ US$19.3910.4% of flowCommon StockSEC:0001209191-20-046134:0
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    1M USD34SEC
    22,554 shares@ US$48.0025.7% of flowCommon StockSEC:0001209191-20-046134:1
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    72,713 USD19SEC
    3,750 shares@ US$19.391.7% of flowCommon StockSEC:0001209191-20-046134:2
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    63,000 USD19SEC
    3,500 shares@ US$18.001.5% of flowCommon StockSEC:0001209191-20-046134:3
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    155,863 USD19SEC
    3,928 shares@ US$39.682.1% of flowCommon StockSEC:0001209191-20-037710:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    72,463 USD19SEC
    2,156 shares@ US$33.611.0% of flowCommon StockSEC:0001209191-20-035697:0
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    193,825 USD19SEC
    4,881 shares@ US$39.712.7% of flowCommon StockSEC:0001209191-20-020120:0
  • ▼
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    243,540 USD19SEC
    9,239 shares@ US$26.363.4% of flowCommon StockSEC:0001209191-20-020120:1
  • ◆
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    0SEC
    40,000 shares0Common StockSEC:0001209191-20-020120:2
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    63,000 USD19SEC
    18,000 shares@ US$3.500.6% of flowCommon StockSEC:0001209191-19-061939:0
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    124,950 USD19SEC
    21,000 shares@ US$5.951.2% of flowCommon StockSEC:0001209191-19-061939:1
  • ◇
    SVP, Finance and CFOExecutivesKyntra Bio, Inc.
    251,563 USD19SEC
    17,254 shares@ US$14.582.4% of flowCommon StockSEC:0001209191-19-061939:2

25 of 152 declarations